Global Cancer Diagnostics Device Market Growth 2023-2029

Global Cancer Diagnostics Device Market Growth 2023-2029

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.

LPI (LP Information)' newest research report, the “Cancer Diagnostics Device Industry Forecast” looks at past sales and reviews total world Cancer Diagnostics Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Diagnostics Device sales for 2023 through 2029. With Cancer Diagnostics Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Diagnostics Device industry.

This Insight Report provides a comprehensive analysis of the global Cancer Diagnostics Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Diagnostics Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cancer Diagnostics Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Diagnostics Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Diagnostics Device.

The global Cancer Diagnostics Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Diagnostics Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Companion Diagnostics
Molecular Diagnostics

Segmentation by application
Lung
Breast
Colorectal
Prostate
Cervical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cancer Diagnostics Device market?

What factors are driving Cancer Diagnostics Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cancer Diagnostics Device market opportunities vary by end market size?

How does Cancer Diagnostics Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.